ScholarWorks@Korea University College of Medicine: Kang, Sung Hoon

Detailed Information

Kang, Sung Hoon (강성훈)

Guro Hospital (Department of Neurology, Guro Hospital)

Research Area: 알츠하이머병 및 관련 바이오마커, 뇌영상 및 인공지능, 피질하혈관성 치매 및 기타 치매, Alzheimer's disease and associated biomarkers, Neuro-image and AI, Subcortical vascular dementia and other cause of dementia

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Alzheimer's disease:7||Parkinson's disease:6||amyloidbeta (A beta):2||primary progressive aphasia:2||Gender:2||Amyloidbeta:2||Cognitive decline:2||Cognitive impairment:2||tau:2||depression:2||Amyloidbeta (A beta):2||Gait:2||BMI variability:1||Biomarkers:1||Brain Infarction:1||Brain age:1||Cadence:1||Cardiometabolic syndrome:1||Cerebral small vessel disease:1||Cerebrospinal Fluid:1||Classification:1||Cognition:1||Cognitive trajectories:1||Concordance:1||Constipation:1||Conversion:1||Cortical Atrophy:1||Cortical atrophy:1||Essential tremor:1||Ethnicity:1||Fat:1||Frontal executive function:1||Frontalexecutive function:1||Genomewide association studies:1||H. pylori:1||HDLc:1||Harmonisation:1||Hippocampal volume:1||Intracranial Embolism:1||Keywords Dance:1||LDLc:1||Longitudinal studies:1||MRI:1||Mild cognitive impairment:1||MiniMental State Examination:1||Montreal Cognitive Assessment:1||Motor:1||Muscle:1||NAFLD:1||Neural Correlates:1||Neural substrate:1||Neurogenic orthostatic hypotension:1||Neuropsychological Tests:1||Neuropsychological test:1||Nonmotor:1||Optical coherence tomography angiography:1||PET:1||PET classifier:1||PSEN1 mutation:1||Parkinson's disease dementia:1||Positron Emission Tomography:1||Positron emission tomography:1||Poststroke cognitive impairment (PSCI):1||Quality of life:1||Risk factor:1||Small subcortical infarction:1||Stride length:1||Stride time:1||Subcortical vascular cognitive impairment:1||Subcortical vascular dementia:1||Surface electromyogram:1||Thigh:1||Tremor dominant:1||Validation:1||White matter hyperintensity (WMH):1||amnestic mild cognitive impairment:1||attention:1||betaAmyloidbeta (A beta):1||betaamyloid:1||biomarker:1||body mass index (BMI):1||cardiometabolic syndrome:1||cardiometabolic syndromes:1||cerebral amyloid angiopathy:1||cerebrospinal fluid:1||cognitive impairment:1||comprehension:1||cortical atrophy:1||de novo Parkinson's disease:1||dementia:1||frontal executive function:1||functional disability:1||gait disturbance:1||generative naming:1||hydrocephalus:1||hypertension:1||incidence:1||incidence rate:1||language:1||language function test:1||machine learning:1||magnetic resonance imaging:1||magnetic resonance imaging features:1||modifiable risk factor:1||mortality:1||neural substrate:1||neurodegeneration:1||neuropsychological tests:1||nonmotor symptom:1||object naming:1||osteoporosis:1||positron emission tomography:1||preclinical stage of Alzheimer's disease:1||prediction model:1||psychosis:1||risk factors:1||sex:1||siderosis:1||subcortical vascular cognitive impairment:1||white matter hyperintensities:1||18Fflutemetamol PET:1||ßAmyloid:1||A beta positivity:1||Age:1||Alzheimer Disease:1||Alzheimer's Continuum:1||Alzheimer's Disease:1||Alzheimer’s disease:1||Amyloid:1||Atrial fibrillation:1||Aβ PET:1||Aβ positivity:1||BMI change:1||

STATISTICS: Total View :12,811,392; Today View :8,177

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE